Using IMPROVE to guide carotid revascularisation decisions
Official title: Clinical Impact of the Use of IMPROVE for Selection of Patients for Carotid Revascularisation: a Randomized Controlled Multicentre Non-inferiority Trial in Symptomatic Patients With 30-99% Carotid Stenosis
Run by Maastricht University Medical Center · NCT07556887 · Data updated 2026-11-12
This trial tests whether using the IMPROVE MRI-based score to select patients for carotid revascularisation is as good as standard care based mainly on stenosis degree, among people who have had a recent stroke or TIA due to carotid disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 613 (estimated) |
| Sponsor | Maastricht University Medical Center Academic / other |
| Locations | 10 sites (Arnhem, Gelderland and 9 other locations) |
| Status | Recruiting |
| Started | March 31, 2026 |
| Main results expected | August 31, 2028 |
| Study ends | August 31, 2031 |
| Registry record updated | May 15, 2026 |
| Trial ID | NCT07556887 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18+ with a recent stroke or TIA (<30 days), 30–99% carotid stenosis confirmed by NASCET criteria, suitable for revascularisation, and willing to be randomised to IMPROVE-based or standard selection.
✕Probably not a fit
Patients with non-atherosclerotic carotid disease, MRI contraindications, pregnancy, or those unlikely to benefit from revascularisation may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares an IMPROVE-based patient selection method against usual care for carotid revascularisation in symptomatic carotid stenosis. Eligible adults with recent stroke or TIA and 30–99% ipsilateral stenosis will be randomized to treatment selection by IMPROVE risk scoring or by conventional criteria, with follow-up over several years to assess health outcomes and costs. The IMPROVE model combines MRI plaque vulnerability (intraplaque haemorrhage) with clinical risk factors to predict stroke risk and guide whether revascularisation is beneficial. The study aims to determine if IMPROVE-based selection reduces recurrent stroke or other vascular events and lowers overall costs compared with standard selection. Primary outcomes include stroke recurrence and health-economic impact, with safety and feasibility as secondary considerations.
Why it matters
Potential benefit: If successful, patients may receive revascularisation more accurately when beneficial, potentially reducing strokes and healthcare costs.
How similar studies have gone: Prior work suggests MRI-based plaque vulnerability can improve stroke risk prediction; this study tests its impact on treatment decisions in a randomized design.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Mentally competent * 18 years or older * Recent (\<30 days) stroke (modified Rankin scale ≤3) or TIA * Ipsilateral 30-99% atheromatous stenosis at the carotid bifurcation assessed using non-invasive imaging according to NASCET criteria * Life expectancy \>5 years * Patient and stenosis are suitable for carotid revascularisation * Patient is agreeable to randomisation and willing to accept either IMPROVE-based or CAU-based selection method for carotid revascularisation Exclusion Criteria: * Cardiac source of embolism * Carotid stenosis caused by non-atherosclerotic disease e.g. dissection, fibromuscular disease or neck radiotherapy. * MRI contra-indications * Pregnancy
Where it's running
-
Maastricht University
Maastricht, Limburg, Netherlands Recruiting -
Rijnstate
Arnhem, Gelderland, Netherlands Not yet recruiting -
Radboud UMC
Nijmegen, Gelderland, Netherlands Not yet recruiting -
Zuyderland
Heerlen, Limburg, Netherlands Not yet recruiting -
Amsterdam UMC
Amsterdam, North Holland, Netherlands Not yet recruiting -
Isala
Zwolle, Overijssel, Netherlands Not yet recruiting
Show 4 more locations
-
Albert Schweitzer Ziekenhuis
Dordrecht, South Holland, Netherlands Not yet recruiting -
Erasmus MC
Rotterdam, South Holland, Netherlands Not yet recruiting -
Haaglanden MC
The Hague, South Holland, Netherlands Not yet recruiting -
Utrecht UMC
Utrecht, Utrecht, Netherlands Not yet recruiting
Study contacts
- Principal investigator: M. Eline Kooi, Prof. dr. — Maastricht University
- Study coordinator: M. Eline Kooi, Prof. dr.
- Email: improve.trial@mumc.nl
- Phone: +31 43 387 4911
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
Emergency Stroke Unit for treating acute strokes
This study is testing a new Emergency Stroke Unit that uses a mobile MRI to see if it can help treat stroke patients faster and improve their recovery.
-
NeuroAiD test in mild to moderate ischemic stroke patients
This study tests whether adding MLC901 (NeuroAiD II) to standard stroke care helps adults who recently had an ischemic stroke recover better than standard care alone.
-
Self-Supervised Constraint-Induced Movement Therapy for Stroke Recovery
This study tests a partly self-guided therapy program to help adults recover the use of their weaker arm after stroke, aiming to require less time with a therapist.
-
Savvy medication-support program for people after stroke
This project will test whether Savvy — short phone-based psychological exercises, a weekly pill organizer, and text reminders — helps stroke survivors take their blood-pressure medicines and improve blood pressure compared with usual care.
-
Vojta therapy to improve posture and trunk control after stroke
This study will see if adding Vojta reflex locomotion therapy to routine physical therapy helps adults with recent ischemic stroke improve posture, trunk control, and arm movement.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.